Asio Capital’s AbbVie ABBV Stock Holding History

Asio Capital’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.24M	Sell	4,927 -181	-4%	-$38.9K	0.16%	80
2026 Q1	$1.11M	Sell	5,108 -44	-0.9%	-$9.76K	0.16%	79
2025 Q4	$1.18M	Sell	5,152 -23	-0.4%	-$5.24K	0.17%	78
2025 Q3	$1.2M	Buy	5,175 +6	+0.1%	+$1.22K	0.18%	78
2025 Q2	$959K	Sell	5,169 -18	-0.3%	-$3.35K	0.16%	81
2025 Q1	$1.09M	Sell	5,187 -5	-0.1%	-$972	0.21%	80
2024 Q4	$923K	Buy	5,192 +113	+2%	+$20.8K	0.17%	80
2024 Q3	$1M	Sell	5,079 -26	-0.5%	-$4.85K	0.19%	78
2024 Q2	$876K	Sell	5,105 -5	-0.1%	-$828	0.18%	77
2024 Q1	$931K	Buy	5,110 +35	+0.7%	+$6.03K	0.2%	76
2023 Q4	$786K	Sell	5,075 -10	-0.2%	-$1.46K	0.18%	79
2023 Q3	$758K	Sell	5,085 -7,492	-60%	-$1.1M	0.2%	80
2023 Q2	$1.69M	Sell	12,577 -12,569	-50%	-$1.84M	0.42%	76
2023 Q1	$4.01M	Buy	25,146 +388	+2%	+$59.3K	1.04%	31
2022 Q4	$4M	Sell	24,758 -51	-0.2%	-$7.82K	1.15%	32
2022 Q3	$3.33M	Sell	24,809 -4,555	-16%	-$654K	1.06%	34
2022 Q2	$4.5M	Buy	29,364 +177	+0.6%	+$27K	1.42%	15
2022 Q1	$4.73M	Sell	29,187 -10,576	-27%	-$1.54M	1.33%	17
2021 Q4	$5.38M	Buy	39,763 +1,181	+3%	+$140K	1.68%	14
2021 Q3	$4.16M	Buy	38,582 +1,497	+4%	+$171K	1.44%	20
2021 Q2	$4.18M	Buy	37,085 +2,168	+6%	+$244K	1.48%	18
2021 Q1	$3.78M	Buy	34,917 +6,781	+24%	+$725K	1.56%	16
2020 Q4	$3.02M	Buy	28,136 +1,690	+6%	+$162K	1.45%	29
2020 Q3	$2.32M	Buy	26,446 +6,183	+31%	+$582K	1.27%	36
2020 Q2	$1.99M	Buy	20,263 +3,603	+22%	+$317K	1.26%	34
2020 Q1	$1.27M	Buy	+16,660	New	+$1.42M	1.08%	49

Other funds holding ABBV

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.94% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

Asio Capital's ABBV Position: Q2 2026 in Review

Asio Capital reduced its AbbVie (ABBV) stake by 3.5% in Q2 2026, selling an estimated $38.9K and leaving 4,927 shares worth $1.24M. The position accounts for 0.16% of the portfolio, ranked #80.

Asio Capital first reported a position in ABBV in Q1 2020 and has held it in 26 quarters since. The position peaked at $5.38M in Q4 2021. 2,345 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Asio Capital held 4,927 shares of AbbVie worth $1.24M as of Q2 2026.
Asio Capital sold 181 AbbVie shares in Q2 2026, an estimated $38.9K.
AbbVie made up 0.16% of Asio Capital's portfolio in Q2 2026, its #80 holding.
Asio Capital first reported a position in AbbVie in Q1 2020 and has held it in 26 quarters since.
Asio Capital's AbbVie position peaked at $5.38M in Q4 2021.
2,345 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Asio Capital's 13F filing for Q2 2026, filed 17 Jul 2026.